Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Vitiligo Clinical Trials
Vitiligo clinical trials are recruiting across 41 cities. Here are the cities with the most active studies:
Vitiligo Trial Phases
9 research organizations are sponsoring vitiligo trials.
About Vitiligo
Vitiligo is a condition that causes loss of skin color in patches due to destruction of melanocytes. It affects about 1% of the global population. Treatment options include topical corticosteroids, phototherapy, JAK inhibitors, and skin grafting.
Clinical trials are advancing new treatments for vitiligo. Currently, 9 studies are recruiting a combined 2,003,321 participants across the United States. Research is being conducted by 9 organizations including Target PharmaSolutions, Inc., CorEvitas, Novartis Pharmaceuticals and 6 others.
2026 Vitiligo Research Landscape
As of August 2026, the vitiligo clinical trial landscape includes 9 actively recruiting studies across 41 cities in the United States. These studies are collectively seeking 2,003,321 participants, with an average enrollment target of 222,591 per study.
The research spans multiple phases of development: 5 studies are in PHASE2, 1 study is in PHASE3. The presence of Phase 3 trials indicates that some vitiligo treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 9 different organizations, including Target PharmaSolutions, Inc., CorEvitas, Novartis Pharmaceuticals, Takeda, Incyte Corporation, and 4 others.
Geographically, vitiligo trials are most concentrated in Birmingham, Alabama (2 trials); Fountain Valley, California (2 trials); San Diego, California (2 trials); Hollywood, Florida (2 trials); Miami, Florida (2 trials) and 7 other cities.
Featured Vitiligo Studies
Highlighted recruiting studies for vitiligo, selected by enrollment size and research scope.
An Observational Study of Patients With Dermatologic Disease
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from pat...
PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.
Frequently Asked Questions About Vitiligo Clinical Trials
Are there vitiligo clinical trials near me?
Yes, there are 9 vitiligo clinical trials currently recruiting across 41+ cities in the United States, including Birmingham, Alabama; Fountain Valley, California; San Diego, California. Browse the studies above to find one at a location convenient for you.
How do I join a vitiligo clinical trial?
To join a vitiligo clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are vitiligo clinical trials free?
Yes, participation in vitiligo clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of vitiligo treatments are being studied?
Current vitiligo clinical trials are testing a range of approaches across PHASE2 (5 studies), PHASE3 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 9 research organizations.
Is it safe to participate in vitiligo clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated August 30, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated August 30, 2026 · Data from ClinicalTrials.gov